Worldwide Clinical Trials Selects BioClinica's OnPoint CTMS To Deliver Trial Management Technology For Global Sponsors
- Solution Drives Clinical Study Efficiencies and Cost Savings -
NEWTOWN, Pennsylvania, March 6, 2014 /PRNewswire/ -- BioClinica®, Inc., a global provider of technology-enhanced clinical trial management solutions, today announced that Worldwide Clinical Trials, Inc. has selected BioClinica's OnPoint CTMS (clinical trial management system) to support international studies spanning all phases of drug development in diverse therapeutic areas. By implementing BioClinica's web-based OnPoint CTMS the global, full-service contract research organization (CRO) anticipates improved efficiencies in data flow and workflow with cost-savings in time, labor, and operational expenses.
Photo - http://photos.prnewswire.com/prnh/20130403/PH87647LOGO
"We believe well-integrated technologies enhance clinical development and the decision to replace our existing trial management system with BioClinica's OnPoint reflects this. It also gives us broader functionality along with predictable pricing," said Tom Wardle, Chief Operating Officer, Worldwide Clinical Trials. "After conducting an extensive evaluation of industry-leading CTMS providers, we selected OnPoint for its flexibility, scalability, and superior technical support." BioClinica's Office-smart CTMS utilizes Microsoft SharePoint to foster collaboration and connectivity in multi-site study environments.
OnPoint will provide role-based access to hundreds of Worldwide Clinical Trials users around the globe, including clinical research associates, monitors, study managers, operations and site personnel, as well as executives and sponsor users. "BioClinica's OnPoint will help us to deliver the right solution for each trial and every sponsor," Wardle said.
BioClinica's Peter Benton, President of eClinical Solutions explained, "With the large amount of data generated across so many trials and individual study activities, it can be hard to control and manage it all. Because OnPoint handles studies of any size and complexity securely and compliantly, we're seeing wide adoption by major players like Worldwide Clinical Trials and Harvard Clinical Research Institute. Everyone who sees our MVR wants it." BioClinica's innovative Monitor Visit Report (MVR) replaces conventional manual transcription with an electronic visit report that can be securely accessed and updated anytime and anywhere whether online or offline. BioClinica's MVR can save thousands of labor hours and dramatically reduce clinical trial costs. The achievement earned BioClinica a 2012 Microsoft Life Sciences Innovation Award.
OnPoint manages a clinical trial from the start and maintains role-based access control across the continuum, from study design through close-out and FDA submission. The end-to-end clinical trial management solution includes the tools to plan, startup, conduct, and manage studies and complete monitoring and regulatory compliance activities. It supports every study aspect, whether design, procedures, protocol, study arms, visits, forms, treatments, or payment.
BioClinica will host a complimentary webinar Primer for Data Managers on 2013 FDA Guidance and Regulations in an Age of eClinical Innovation on March 18 and hold its annual Global User Conference May 5 – 7 in Philadelphia, Pennsylvania.
Follow BioClinica on the Trial Blazers blog at www.bioclinica.com/blog, and on Twitter at http://twitter.com/bioclinica.
About BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. A 2013 merger with CoreLab Partners has created a new standard in imaging core lab services including electronic transfer, management, and independent review; cardiovascular safety monitoring including automated ECG, Thorough QT studies, Holter monitoring, ambulatory blood pressure monitoring and pulse wave analysis; and eClinical solutions for electronic data capture, randomization, clinical trial management, and clinical supply chain forecasting and optimization. BioClinica offers unmatched scientific expertise with a team of respected medical researchers and board certified, sub-specialty trained radiologists, cardiologists, nuclear medicine physicians and oncologists. With more than 28 years of experience and over 3000 successful trials to date, BioClinica has supported the development of many new medicines through all phases of the clinical trial process. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide comprehensive cardiovascular safety, and eClinical and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com.
About Worldwide Clinical Trials, Inc.
Worldwide Clinical Trials is a global, full-service contract research organization (CRO) that is medically and scientifically focused on central nervous system, cardiovascular, chronic inflammatory, respiratory and oncology disorders. Worldwide Clinical Trials delivers quality clinical trials with leading edge science and medicine to help clients think through design, methodology and regulatory issues that are unique to every development program. Worldwide Clinical Trials provides highly focused CRO services in all phases of research. For more information, visit www.wwctrials.com.
SOURCE BioClinica, Inc.